Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning

Journal of Applied Toxicology

Volumn 26, Issue 1, 2006, Pages 56-63

  Vrdoljak, A Lucić ^a   Radic B ^a   Garaj Vrhovac, V ^a   Kopjar, N ^a   Zlender V ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Adamantanes; Brain acetylcholinesterase activity; Comet assay; Genotoxic effects; N methyl D aspartate (NMDA) receptors; Soman

Indexed keywords

1 [2 (2 THIENYL) 2 ADAMANTYL]MORPHOLINE; ACETYLCHOLINESTERASE; ADAMANTANE DERIVATIVE; ANTIDOTE; ATROPINE; CARBAMIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHYSOSTIGMINE; SOMAN; TAMORF; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG POTENCY; ENZYME ACTIVITY; GENOTOXICITY; INTOXICATION; LD 50; MALE; NEUROPROTECTION; NONHUMAN; ORGANOPHOSPHATE INTOXICATION; PRIORITY JOURNAL; RAT; SEIZURE;

ACETYLCHOLINESTERASE; ADAMANTANE; ANIMALS; ANTICONVULSANTS; ANTIDOTES; BRAIN; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; COMET ASSAY; LEUKOCYTES; LIVER; MALE; MORPHOLINES; NEUROPROTECTIVE AGENTS; POISONING; RATS; RATS, WISTAR; SOMAN;

ANIMALIA;

EID: 31744444438     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1105     Document Type: Article

References (39)

1. Capacio BR, Shih TM. 1991. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 32: 604-615.
2. Carpentier P, Foquin-tarricone A, Bodjarian N, Rondouin G, Lerner-Natoli M, Kamenka J-M, Blancher G, Denoyer M, Lallement G. 1994. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 15: 837-852.
3. Clinton ME, Misulis KE, Dettbarn WD. 1988. Effects of phenytoin, ketamine, and atropine methyl nitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropyl-phosphorofluoridate. J. Toxicol. Environ. Health 24: 439-449.
4. Cohen MG, Chan SL, Bhargava HN, Trevor AJ. 1974. Inhibition of mammalian brain acetylcholinesterase by ketamine. Biochem. Pharmacol. 23: 1647-1652.
5. Ellman GL, Courtney KD, Andres VJr, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95.
6. Fusek J, Bajgar J, Patocka J. 1996. The biological effects of highly toxic carbamates. ASA Newslett. 96-354: 13-14.
7. Gabrielewitz A, Kloog Y, Kalir A, Balderman D, Sokolovsky M. 1980. Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors. Life Sci. 26: 89-95.
8. Lallement G, Carpentier P, Pernot-Marino I, Baubichon D, Collet A, Blanchet G. 1991. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: An autoradiographic study. Neurotoxicology 12: 656-664.
9. Lallement G, Clarencon D, Masqueliz C, Baubichon D, Gallonier M, Burckhart MF, Peoc'h M, Mestries J-C. 1998b. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch. Toxicol. 72: 84-92.
10. Lallement G, Delamanche I, Pernot-Marino I, Baubichon D, Denoyer M, Carpentier P, Blanchet G. 1993. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: Quantification with an omega 3 site ligand. Brain Res. 618: 227-237.
11. Lallement G, Denoyer M, Collet A, Pernot-Marino I, Baubichon D, Monmaur P, Blanchet G. 1992. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: Influence of septal cholinoceptive cells. Neurosci. Lett. 139: 104-107.
12. Lallement G, Dorandeu F, Filliat P, Carpentier P, Bailie V, Blanchet G. 1998a. Medical management of organophosphate induced seizures. J. Physiol. (Paris) 92: 369-373.
13. Lallement G, Pernot-Marino I, Foquin-Tarricone A, Baubichon D, Piras A, Blanchet G, Carpentier P. 1994. Coadministration of atropine, NBQX and TCP against soman-induced seizures. Neuroreport 5: 1113-1117.
14. Lemercier G, Carpentier P, Sentenac-Roumanou H, Morelis P. 1983. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. 61: 123-129.
15. McDonough JH, Jaax NK, Crowley RA, Mays MZ, Modrow HE. 1989. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13: 256-276.
16. McDonough J, Shih TM. 1993. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17: 203-215.
17. Mion G, Tourtier JP, Petitjeans F, Dorandeu F, Lallement G, Rüttimann M. 2003. Neuroprotective and antiepileptic activities of ketamine in nerve agent poisoning. Anesthesiology 98: 1517.
18. Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayashi H, Okudera H, Nohara M, Midorikawa Y, Mimura S. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 364: 290-293.
19. Okudera H, Morita H, Iwashita T, Shibata T, Odagir T, Kobayashi S, Yanagisawa N. 1997. Unexpected nerve gas exposure in the city of Matsumoto: Report of rescue activity in the first sarin gas terrorism. Am. J. Emerg. Med. 15: 527-528.
20. Otomi S, Takase M, Kumagai F. 1996. Sarin poisoning in Japan: A clinical experience in Japan Self Defence Force (JSDF) Central Hospital. Int. Rev. Armed Forces Med. Serv. 4-6: 97-102.
21. Philippens IHCHM, Vanwersch RAP, Groen B, Olivier B, Bruijnzeel PLB, Melchers BPC. 2000. Subchronic physostigmine pretreatment in marmosets: Absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol. Sci. 53: 84-91.
22. Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA. 1999. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology 20: 551-559.
23. Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R. 2002. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23: 7-17.
24. Schneir AB, Offerman SR, Ly BT. 2003. Complications of diagnostic physostigmine administration to emergency department patients. Ann. Emerg. Med. 42: 14-19.
25. Schuh FT. 1975. Influence of ketamine on human plasma cholinesterase. Br. J. Anaesth. 47: 1315-1319.
26. Shih TM, Koviak TA, Capacio BR. 1991. Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neurosci. Biobehav. Rev. 15: 349-362.
27. Shih TM, McDonough JH, Jr. 1997. Neurochemical mechanisms in soman-induced seizures. J. Appl. Toxicol. 64: 225-264.
28. Shih TM, McDonough JH, Koplowitz I. 1999. Anticonvulsants for soman-induced seizure activity. J. Biomed. Sci. 6: 86-96.
29. Singh NP. 2000. Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis. Mutat. Res. 455: 111-127.
30. Singh NP, Mc Coy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 175: 184-191.
31. Škare D, Radić B, Lucić A, Peraica M, Domijan A-M, Milković-Kraus S, Bradamante V, Jukić I. 2002. Adamantyl tenocyclidines-adjuvant therapy in poisoning with organophosphorus compounds and carbamates. Arch. Toxicol. 76: 173-177.
32. Srivatsan M. 1999. Effects of organophosphates on cholinesterase activity and neunte regeneration in Aplysia. Chem. Biol. Interact. 119-120: 371-378.
33. Taylor P. 1996. Anticholinesterase agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE, Malinoff PB, Ruddon RW, Gillman AG (eds). McGraw-Hil: New York; 161-176.
34. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35: 206-221.
35. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD. 1989. The behavioral effects of MK-801; a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167: 127-135.
36. Vale JA. 1995. Oximes - useless and harmful? Przeglad Lekarski 52: 201.
37. Vaupel DB, McCoun D, Cone EJ. 1984. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse. J. Pharmacol. Exp. Ther. 230: 20-27.
38. Williams BR. 1999. Metrifonate: A new agent for the treatment of Alzheimer's disease. Am. J. Health Syst. Pharm. 56: 427-432.
39. Worek F, Backer M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. 1997. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 16: 466-472.